Follow the NYMOX PHARMACEUTICAL CORP stock price and the full insider trade history of the company, a publicly traded company based in United States. Shares trade on the US market, under the oversight of SEC (Form 4). Market capitalisation: €19k. The latest transaction was filed on 26 June 2023 (Acquisition). Among the most active insiders: Robinson James George. Every trade is free.
15
Insider Decl.
n/a
Thresholds
€32,792
15 ops.
Buy Volume
n/a
n/a
Sell Volume
20Σ signal
Buys €32,792n/a Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
NYMOX PHARMACEUTICAL CORP is a biopharmaceutical company focused on developing treatments for age-related diseases. It is listed on NASDAQ under the symbol NYMX.